| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2004 ( Subtotal = $50,000 ) |
| 2004 | 2004 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R01CA101008 | SILIBININ IN PROSTATE CANCER CHEMOPREVENTION & TREATMENT | 000 | 2 | NIH | 9/21/2004 | $50,000 |
|
 | Issue Date FY: 2003 ( Subtotal = $50,000 ) |
| 2003 | 2003 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R01CA101008 | SILIBININ IN PROSTATE CANCER CHEMOPREVENTION & TREATMENT | 000 | 1 | NIH | 9/30/2003 | $50,000 |
|
 | Issue Date FY: 2002 ( Subtotal = $87,927 ) |
| 2002 | 2002 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R01CA090648 | TRICYCLIC ANTIDEPRESSANTS AS RISKS FACTORS FOR CANCER | 000 | 2 | NIH | 5/31/2002 | $87,927 |
|
 | Issue Date FY: 2001 ( Subtotal = $215,289 ) |
| 2001 | 2001 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R01AI043878 | DELETION MUTAGENESIS WITHIN NONCODING SEGMENTS OF HIV1 | 001 | 3 | NIH | 9/21/2001 | $75,000 |
| 2001 | 2001 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R01CA090648 | TRICYCLIC ANTIDEPRESSANTS AS RISKS FACTORS FOR CANCER | 000 | 1 | NIH | 3/30/2001 | $140,289 |
|
 | Issue Date FY: 2000 ( Subtotal = $195,299 ) |
| 2000 | 2000 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R01AI043878 | DELETION MUTAGENESIS WITHIN NONCODING SEGMENTS OF HIV1 | 000 | 3 | NIH | 7/21/2000 | $195,299 |
|
 | Issue Date FY: 1999 ( Subtotal = $459,623 ) |
| 1999 | 1999 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R03CA078205 | PHASE I TRIAL OF SARCNU | 000 | 2 | NIH | 8/24/1999 | $50,000 |
| 1999 | 1999 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R01CA078698 | HORMONAL REPLACEMENT THERAPY AND RISK OF COLON CANCER | 000 | 2 | NIH | 9/1/1999 | $39,832 |
| 1999 | 1999 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R37AG007444 | GROWTH CONTROL IN AGING FIBROBLASTS | 000 | 12 | NIH | 4/30/1999 | $174,492 |
| 1999 | 1999 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R01AI043878 | DELETION MUTAGENESIS WITHIN NONCODING SEGMENTS OF HIV1 | 000 | 2 | NIH | 7/12/1999 | $195,299 |
|
 | Issue Date FY: 1998 ( Subtotal = $812,123 ) |
| 1998 | 1998 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R03CA078205 | PHASE I TRIAL OF SARCNU | 000 | 1 | NIH | 9/21/1998 | $50,000 |
| 1998 | 1998 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R01AG011903 | TROPHIC FACTOR INDUCED SYNAPTIC REGROWTH IN THE CNS | 001 | 3 | NIH | 3/11/1998 | $42,115 |
| 1998 | 1998 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R37AG007444 | GROWTH CONTROL IN AGING FIBROBLASTS | 000 | 11 | NIH | 7/22/1998 | $169,440 |
| 1998 | 1998 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R01AG009278 | FIBROBLAST AGING AND PROGRAMMED CELL DEATH | 000 | 8 | NIH | 8/21/1998 | $143,402 |
| 1998 | 1998 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R01AI043878 | DELETION MUTAGENESIS WITHIN NONCODING SEGMENTS OF HIV1 | 000 | 1 | NIH | 7/29/1998 | $195,299 |
| 1998 | 1998 | JEWISH GENERAL HOSPITAL | 4333 COTE STE CATHERINE ROAD | MONTREAL, QUEBEC | | 00000 | | CAN | R01CA078698 | HORMONAL REPLACEMENT THERAPY AND RISK OF COLON CANCER | 000 | 1 | NIH | 9/10/1998 | $211,867 |
|
|